Adlai Nortye Ltd. ( ANL) - Key Metrics
ANL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $0.23 | -$0.81 | -$3.14 | -$3.15 |
| 2025Q3 | $0.23 | -$0.81 | -$0.86 | -$0.87 |
| 2025Q2 | $0 | $0 | $0 | $0 |
| 2024Q4 | $0 | $0 | $0 | $0 |
| 2024Q2 | $0.09 | -$1.59 | -$1.63 | -$1.64 |
ANL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | 0% | -0.44 |
| 2025Q3 | 0% | -0.56 |
| 2025Q2 | 0% | 0 |
| 2024Q4 | 0% | 0 |
| 2024Q2 | 0% | -0.57 |
ANL
Price: $13.72
52 week price:
Earnings Per Share: -0.66 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 922.8 million